Redistribution of body composition in patients with Graves' disease after iodine-131 treatment

被引:5
|
作者
Xie, L-J [1 ]
Zhou, H-J [2 ]
Li, J-F [1 ]
Zhang, F. [1 ]
Zeng, F-W [1 ]
Qin, L-P [1 ]
Chen, Y. [1 ]
Yuan, H-J [1 ]
Cheng, M-H [1 ]
机构
[1] Sun Yat Sen Univ, Dept Nucl Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Internal Med, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China
关键词
X-RAY ABSORPTIOMETRY; SERUM LEPTIN LEVELS; SKELETAL-MUSCLE; MASS INDEX; THYROID-HORMONE; RADIOIODINE TREATMENT; ENERGY-EXPENDITURE; HYPERTHYROIDISM; BONE; HYPOTHYROIDISM;
D O I
10.1038/ejcn.2014.232
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
OBJECTIVE: The objective of this study was to investigate body composition redistribution at 3 months after radioactive iodine therapy (RAI). METHODS: Eighty patients with Graves' disease (GD) for RAI and 18 volunteers were recruited. All patients underwent thyroid status test and dual-energy x-ray absorptiometry at baseline and 3 months after RAI. According to the second thyroid status test, patients were divided into the following groups: A, with aggravated hyperthyroidism; B-1, with improved hyperthyroidism; B-2, with euthyroidism; and B-3, with hypothyroidism. RESULTS: Total lean mass (LM) but fat mass (FM) and bone mineral content (BMC) of whole GD patients after RAI recovered to be not different with controls. Compared with baseline, in group A, FM in the left leg increased, and LM in left arm, right arm, trunk and total LM decreased (P<0.05). In B-2, FM in the head increased, and LM in the head, right arm, trunk and total LM increased (P<0.05). In B-3, FM in the right leg and total body fat percentage decreased, but FM in the head, android-to-gynoid fat ratio and body mass index increased (P<0.05); LM of all sites, weight and total mass increased (P<0.05); BMC in lumbar spine and left leg, and total BMC decreased (P<0.05). Body composition of unmentioned sites was retained after RAI in each group (P>0.05). CONCLUSIONS: Replenishment of LM gets priority rather than FM and BMC during the first 3 months after RAI, and the increase in LM starts from the upper body; head is the regional site in which FM recovery occurs first.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 50 条
  • [21] Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves' Disease: A Retrospective Cohort Study
    Yamashita, Kaoru
    Morimoto, Satoshi
    Kimura, Shihori
    Seki, Yasufumi
    Bokuda, Kanako
    Watanabe, Daisuke
    Yazaki, Tomoyo
    Abe, Koichiro
    Ichihara, Atsuhiro
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (05)
  • [22] Analysis of iodine-131-induced early thyroid hormone variations in Graves' disease
    Xu, Feng
    Gu, Aichun
    Pan, Yifan
    Yang, Liwen
    Ma, Yubo
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (11) : 1154 - 1159
  • [23] Follow-up and evaluation of the pregnancy outcome in women of reproductive age with Graves' disease after 131Iodine treatment
    Zhang, Li-Hua
    Li, Jing-Yan
    Tian, Qi
    Liu, Shuang
    Zhang, Hong
    Liu, Sheng
    Liang, Jiu-Gen
    Lu, Xian-Ping
    Jiang, Ning-Yi
    JOURNAL OF RADIATION RESEARCH, 2016, 57 (06) : 702 - 708
  • [24] Iodine-131 treatment of hyperthyroidism: Significance of effective half-life measurements
    Berg, GEB
    Michanek, AMK
    Holmberg, ECV
    Fink, M
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (02) : 228 - 232
  • [26] Weight gain after treatment of Graves' disease in children
    Alonso, Guy Todd
    Rabon, Shona
    White, Perrin C.
    CLINICAL ENDOCRINOLOGY, 2018, 88 (01) : 66 - 70
  • [28] Iodine prophylaxis intensification -: Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease
    Baczyk, M
    Junik, R
    Ziemnicka, K
    Sowinski, J
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2005, 44 (05): : 197 - 199
  • [29] Evaluating the effectiveness of a fixed little dose of radioactive iodine (I131) in treatment for Graves' disease
    Al-Qahtani, Saeed Mueed
    Al-osaimi, Maram Bandar
    Abdelalim, Mahmoud
    Althomali, Marwan Ahmed
    Alomari, Ali Hamed
    Bawazeer, Omemh Abdullah
    Ismail, Asaad H.
    Ajlouni, Abdul-Wali
    JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES, 2023, 16 (03)
  • [30] The efficacy of melatonin against radiotoxicity of iodine-131 and its response to treatment in hyperthyroid patients: a randomized controlled trial
    Alidadi, Soudabe
    Monfared, Ali Shabestani
    Amiri, Mehrangiz
    Zabihi, Ebrahim
    Assadollahi, Ehsan
    Gholami, Amir
    Moazezi, Zoleika
    Abedian, Zeinab
    NUCLEAR MEDICINE REVIEW, 2022, 25 (01) : 31 - 36